A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia

NCT03589326 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

245

Enrollment

INDUSTRY

Sponsor class

Conditions

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Interventions

DRUG: Ponatinib
DRUG: Imatinib
DRUG: Vincristine
DRUG: Dexamethasone
DRUG: Cytarabine
DRUG: Methotrexate
DRUG: Prednisone

Sponsor

Takeda